SOPRO Dental and De Götzen merge to create ACTEON Imaging Unit

Publication
Article
dentalproductsreport.comdentalproductsreport.com-2014-01-01
Issue 1

ACTEON Group has announced it is merging the imaging units of SOPRO dental and De Götzen to create one ACTEON imaging business unit.

ACTEON Group has announced it is merging the imaging units of SOPRO dental and De Götzen to create one ACTEON imaging business unit.

This merger consolidates the companies imaging units which, the company says, will improve customer relations, create synergies in marketing and logistics, and increase growth and efficiencies in both manufacturing and R&D.

According to ACTEON, SOPRO CEO Pierre Montillot will take over as general manager of De Götzen and lead the new ACTEON Imaging management committee.

“This merger is a turning point for our company,” said Gilles Pierson, president and CEO of ACTEON Group. “The new imaging unit will focus on bringing new and exciting products to the market and realize our goal to become the leading dental imaging company in the world.”

With the recent releases of X-Mind Unity and Sopix Inside, the two companies have developed cutting- edge products that have improved the patient experience. 

According to ACTEON, this merger will ensure that there will be many new and innovative products to come in the future.

Recent Videos
2024 Dental Products Report Spring Selection Bracket Reveal Video
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
CDS 2024: Breaking Down Barriers to Care with Eric Kukucka, DD
GNYDM23 Product Focus: CandidPro with Kristin Lange, VP of Sales at Candid
The Connected Future of Dental CAD/CAM with Max Milz
2023 Chicago Dental Society Midwinter Meeting, Interview with Brant Herman, CEO and Founder at MouthWatch and Dentistry.One
Greater New York Dental Meeting 2021 - Interview with Marty Jablow, DMD
 Greater New York Dental Meeting 2021 - Interview with PlanetDDS Vice President of Sales Mike Huffaker
Dentsply Sirona World 2021 - Press Conference
Related Content
© 2024 MJH Life Sciences

All rights reserved.